Cercar
01/05/2024
Preimplantation genetic testing in inherited kidney diseases
Furlano, M, Tinoco, A, Sampani, E, Almeida, C, Goncalves, PL, Polo, A, Martínez, O, Teran, MP, Ramírez, ERV, Ars, E, Torra, R. Preimplantation genetic testing in inherited kidney diseases. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:. PMID:. IF:5.600(Q1/1D).
01/05/2024
Extent of proteinuria in autosomal dominant Alport syndrome compared to X linked Alport syndrome
Goncalves, PL, de Faria, VP, Furlano, M, Almeida, C, Sampani, E, Teran, MP, Viera, E, Fayos, L, Pybus, M, Aza, M, Ars, E, Torra, R. Extent of proteinuria in autosomal dominant Alport syndrome compared to X linked Alport syndrome. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.245. PMID:. IF:5.600(Q1/1D).
01/05/2024
Is class II lupus nephritis as benign as one thinks?
Goncalves, PL, Redondo, GB, Arce, Y, Magallares, B, Castellvi, I, Pasache, HK, Dominguez, A, Barros, X, Rusiñol, HM, Encarnacion, MMD. Is class II lupus nephritis as benign as one thinks?. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.356. PMID:. IF:5.600(Q1/1D).
01/05/2024
Factors affecting disease progression in individuals with heterozygous COL4A3/COL4A4 pathogenic variants
Teran, MP, Furlano, M, Pybus, M, Jiménez, VM, Gomá-Garcés, E, Carrillo, IG, Leon, R, Romeo, MJS, de Arizón, LF, Perera, A, Ars, E, Torra, R. Factors affecting disease progression in individuals with heterozygous COL4A3/COL4A4 pathogenic variants. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:. PMID:. IF:5.600(Q1/1D).
01/05/2024
Clinical spectrum and prognosis of the atypical polycystic kidney disease caused by monoallelic loss-of-function IFT140 variants
Zagorec, N, Calamel, A, Ars, E, Ong, A, Halbritter, J, Audrezet, MP, Pillay, VG, Meur, YL, Sayer, J, Cornec-Le Gall, E. Clinical spectrum and prognosis of the atypical polycystic kidney disease caused by monoallelic loss-of-function IFT140 variants. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.119. PMID:. IF:5.600(Q1/1D).
01/05/2024
Reassuring pregnancy outcomes in women with mild COL4A3-5 - related disease (Alport syndrome) and genetic type of disease can aid personalized counseling
Gosselink, ME, Snoek, R, Cerkauskaite-Kerpauskiene, A, van Bakel, SPJ, Vollenberg, R, Groen, H, Cerkauskiene, R, Miglinas, M, Attini, R, Tory, K, Claes, KJ, van Calsteren, K, Servais, A, de Jong, MFC, Gillion, V, Vogt, L, Mastrangelo, A, Furlano, M, Torra, R, Bramham, K, Wiles, K, Ralston, ER, Hall, M, Liu, LS, Hladunewich, MA, Lely, AT, van Eerde, AM. Reassuring pregnancy outcomes in women with mild COL4A3-5 - related disease (Alport syndrome) and genetic type of disease can aid personalized counseling. KIDNEY INTERNATIONAL. 2024; 105(5)DOI:10.1016/j.kint.2024.01.034. PMID:38382843. IF:12.600(Q1/1D).
05/04/2024
Kidney health matters: a global imperative for public health
Torra, R. Kidney health matters: a global imperative for public health. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39(9)DOI:10.1093/ndt/gfae083. PMID:38578651. IF:5.600(Q1/1D).
01/03/2024
Manejo de la osteoporosis en el paciente con enfermedad renal crónica (Estudio ERCOS): un desafío en la asistencia nefrológica
Bover J., Gómez-Alonso C., Casado E., Rodríguez-García M., Lloret M.J., Castro-Alonso C., Gifre L., Henríquez-Palop F., Prior-Español Á., López de la Manzanara V., Láiz A.M., Martínez-Ferrer À., Torregrosa J.V., Cigarrán S., Górriz J.L., Montomoli M., Panizo N., Costa E., Martínez-Laguna D., Rodríguez M., Navarro-González J.F.. Manejo de la osteoporosis en el paciente con enfermedad renal crónica (Estudio ERCOS): un desafío en la asistencia nefrológica. NEFROLOGIA. 2024; 44(2)DOI:10.1016/j.nefro.2023.05.002. PMID:38531765. IF:2.600(Q2/4D).
01/03/2024
Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?
Lloret, MJ, Jorgensen, HS, Evenepoel, P. Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?. Clinical Kidney Journal. 2024; 17(3)DOI:10.1093/ckj/sfae048. PMID:38500493. IF:4.600(Q1/2D).
01/03/2024
Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care
Bover, J, Gómez-Alonso, C, Casado, E, Rodríguez-García, M, Lloret, MJ, Castro-Alonso, C, Gifre, L, Henríquez-Palop, F, Prior-Español, A, de la Manzanara, VL, Láiz, AM, Martínez-Ferrer, A, Torregrosa, JV, Cigarrán, S, Górriz, JL, Montomoli, M, Panizo, N, Costa, E, Martínez-Laguna, D, Rodríguez, M, Navarro-González, JF. Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care. NEFROLOGIA. 2024; 44(2)DOI:10.1016/j.nefroe.2024.03.005. PMID:. IF:2.600(Q2/4D).
14/02/2024
HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial
Bais, T, Meijer, E, Kramers, BJ, Vart, P, Vervloet, M, Salih, M, Bammens, B, Demoulin, N, Todorova, P, Müller, RU, Halbritter, J, Paliege, A, Gall, ECL, Knebelmann, B, Torra, R, Ong, ACM, Frankl, FEK, Gansevoort, RT. HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial. Trials. 2024; 25(1)DOI:10.1186/s13063-024-07952-x. PMID:38355627. IF:2.000(Q3/7D).
01/02/2024
Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter
Lloret, MJ, Fusaro, M, Jorgensen, HS, Haarhaus, M, Gifre, L, Alfieri, CM, Masso, E, D'Marco, L, Evenepoel, P, Bover, J. Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter. Journal of Clinical Medicine. 2024; 13(4)DOI:10.3390/jcm13041010. PMID:38398323. IF:2.900(Q1/2D).
04/01/2024
Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspective
Lomonte, C, Rossini, M, Ibeas, J, Forcella, M, Ponikvar, JB, Gallieni, M, Russo, R, Goumenos, D, Tesar, V, Hruskova, Z, Roelofs, J, Florquin, S, Snoeijs, M, Giusto, A, Shemesh, D, Rotmans, J, Torra, R, Wanner, C, Gesualdo, L. Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspective. Clinical Kidney Journal. 2024; 17(1)DOI:10.1093/ckj/sfad299. PMID:38213498. IF:4.600(Q1/2D).
01/01/2024
An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD
Taylor J., Thomas R., Metherall P., van Gastel M., Cornec-Le Gall E., Caroli A., Furlano M., Demoulin N., Devuyst O., Winterbottom J., Torra R., Perico N., Le Meur Y., Schoenherr S., Forer L., Gansevoort R.T., Simms R.J., Ong A.C.M.. An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD. Kidney International Reports. 2024; 9(2)DOI:10.1016/j.ekir.2023.10.029. PMID:38344736. IF:5.700(Q1/1D).
01/01/2024
Influence of primary kidney disease in Chronic Kidney Disease pregnancies: pregnancy outcomes in women with COL4A3-5 related disease (Alport Syndrome)
Gosselink, M, Snoek, R, Cerkauskaite-Kerpauskiene, A, Van Bakel, S, Vollenberg, R, Groen, H, Cerkauskiene, R, Miglinas, M, Attini, R, Tory, K, Claes, K, Van Calsteren, K, Servais, A, de Jong, M, Gillion, V, Vogt, L, Mastrangelo, A, Furlano, M, Torra, R, Bramham, K, Wiles, K, Ralston, E, Hall, M, O'Neill, R, Hladunewich, M, Lely, T, van Eerde, AM. Influence of primary kidney disease in Chronic Kidney Disease pregnancies: pregnancy outcomes in women with COL4A3-5 related disease (Alport Syndrome). EUROPEAN JOURNAL OF HUMAN GENETICS. 2024; 32DOI:. PMID:. IF:4.600(Q1/2D).
01/01/2024
Acute kidney injury (AKI): Spanish nomenclature also matters here
Bover, J, Romero-González, G, Chávez-Iñiguez, JS, Rizo-Topete, L, Graterol, F, Santandreu, AV, Sanchez-Baya, M, Díaz, JM, Ortiz, A, Poch, YE. Acute kidney injury (AKI): Spanish nomenclature also matters here. NEFROLOGIA. 2024; 44(1)DOI:https://doi.org/10.1016/j.nefroe.2024.02.009. PMID:. IF:2.600(Q2/4D).
25/12/2023
A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain
Macia, M, Díaz-Encarnación, M, Solans-Laqué, R, Mallol, EP, Castells, AG, Escribano, C, de Arellano, AR. A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain. Expert Review of Pharmacoeconomics & Outcomes Research. 2023; 24(2)DOI:10.1080/14737167.2023.2297790. PMID:38126738. IF:1.800(Q3/6D).
09/11/2023
Replacing a kidney biopsy by exome sequencing in undetermined kidney diseases-not yet ready for prime time!
Torra, R, Kronbichler, A, Bajema, IM. Replacing a kidney biopsy by exome sequencing in undetermined kidney diseases-not yet ready for prime time!. Clinical Kidney Journal. 2023; 17(1)DOI:10.1093/ckj/sfad250. PMID:38186890. IF:3.900(Q1/2D).
01/10/2023
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome
Huerta A., Arjona E., Portoles J., Lopez-Sanchez P., Cavero T., Fernandez-Cusicanqui J., Blasco M., Cabello V., Calvo N., Diaz M., Herrero-Goñi M., Aguirre M., Elías S., Alcaide M.P., Ramos N., Sellares J., Rodríguez de Córdoba S.. On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome. KIDNEY INTERNATIONAL. 2023; 104(4)DOI:10.1016/j.kint.2023.07.020. PMID:37567446. IF:14.800(Q1/1D).
29/09/2023
Treatment and long-term outcome in primary nephrogenic diabetes insipidus
Lopez-Garcia, SC, Downie, ML, Kim, JS, Boyer, O, Walsh, SB, Nijenhuis, T, Papizh, S, Yadav, P, Reynolds, B, Decramer, S, Besouw, M, Carrascosa, MP, La Scola, C, Trepiccione, F, Ariceta, G, Hummel, A, Dossier, C, Sayer, JA, Konrad, M, Keijzer-Veen, MG, Awan, A, Basu, B, Chauveau, D, Madariaga, L, Koster-Kamphuis, L, Furlano, M, Zacchia, M, Marzuillo, P, Tse, Y, Dursun, I, Pinarbasi, AS, Tramma, D, Hoorn, EJ, Gokce, I, Nicholls, K, Eid, LA, Sartz, L, Riordan, M, Hooman, N, Printza, N, Bonny, O, Sancho, PA, Schild, R, Sinha, R, Guarino, S, Jimenez, VM, Peña, LR, Belge, H, Devuyst, O, Wlodkowski, T, Emma, F, Levtchenko, E, Knoers, NVAM, Bichet, DG, Schaefer, F, Kleta, R, European NDI Consortium, Bockenhauer, D. Treatment and long-term outcome in primary nephrogenic diabetes insipidus. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023; 38(10)DOI:10.1093/ndt/gfaa243. PMID:33367818. IF:4.800(Q1/2D).